Compare CDMOs with viral vector manufacturing capabilities for AAV, lentiviral, retroviral, and adenoviral vector production at GMP scale.
138 companies listed
Viral vector manufacturing produces the delivery vehicles for gene therapies and some vaccines. AAV (adeno-associated virus) vectors are the most in-demand, used in approved gene therapies for hemophilia, spinal muscular atrophy, and inherited retinal disease. Lentiviral vectors are used for ex vivo cell therapy manufacturing (CAR-T). Adenoviral vectors serve vaccine platforms.
Production scale and yield are the central challenges. AAV manufacturing typically uses transient transfection of HEK293 cells or baculovirus/Sf9 insect cell systems, with titers significantly lower than monoclonal antibody production. Downstream processing (purification, concentration, formulation) is complex due to the need to separate full from empty capsids, remove host cell DNA, and achieve high purity while maintaining vector potency.
Lentiviral vectors deliver genes into cells ex vivo and are the standard vector for CAR-T and other engineered cell therapies. Every company below names it in its own directory profile.
AAV (adeno-associated virus) vectors are used for in vivo gene therapy, including approved therapies for hemophilia, spinal muscular atrophy and inherited retinal disease. Every company below names it in its own directory profile.
Adenoviral vectors are used mainly for vaccines and oncolytic virus programs. Every company below names it in its own directory profile.
Gamma-retroviral vectors are used for ex vivo gene-modified cell therapies. Every company below names it in its own directory profile.
United States
BioInnovatise is a US-based CDMO specializing in quick-turnaround molecular biology services for early-stage drug discovery. Services include plasmid DNA services, viral vector packaging, and CRISPR-Cas9 services. The company collaborates with researchers in government, academia, and industry, focusing on custom cloning and the early discovery phase of drug development.
France
ABL Inc. (also operating as Ascend Advanced Therapies - ABL Inc.) is a biologics CDMO focused on viral vector GMP manufacturing for gene therapies, vaccines, oncolytic viruses, and immunotherapies. They operate facilities in Rockville, MD (USA) and Strasbourg and Lyon (France), with 35+ years of experience. This is the same entity as ABL (ABL, Inc. / ABL Europe), appearing as a duplicate record in the database.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.